Replies to post #49442 on Biotech Values

[DewDiligence]

>Total joke.<

Evidently. Perhaps such a characterization applies to the company itself. No wonder their stock ticker is PP.

[DewDiligence]

Pipex Pharmaceuticals (PP) sounds like a scam outfit. On today’s CC, management hyped the “drug” for dry AMD, which is a non-starter, IMO (#msg-21105688).

Then they said Lucentis is selling $2B per year, which is a complete fabrication (and irrelevant because Lucentis does not treat dry AMD).

Caveat emptor.